- Home
- AQST vs CMP Comparison
AQST vs CMP Comparison
Compare AQST & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- CMP
- Stock Information
- Founded
- AQST 2004
- CMP 1993
- Country
- AQST United States
- CMP United States
- Employees
- AQST N/A
- CMP N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- CMP Other Metals and Minerals
- Sector
- AQST Health Care
- CMP Basic Materials
- Exchange
- AQST Nasdaq
- CMP Nasdaq
- Market Cap
- AQST 502.6M
- CMP 512.1M
- IPO Year
- AQST 2018
- CMP 2003
- Fundamental
- Price
- AQST $4.41
- CMP $14.48
- Analyst Decision
- AQST Strong Buy
- CMP Buy
- Analyst Count
- AQST 7
- CMP 4
- Target Price
- AQST $9.43
- CMP $31.00
- AVG Volume (30 Days)
- AQST 1.7M
- CMP 781.5K
- Earning Date
- AQST 11-04-2024
- CMP 11-26-2024
- Dividend Yield
- AQST N/A
- CMP 4.12%
- EPS Growth
- AQST N/A
- CMP N/A
- EPS
- AQST N/A
- CMP N/A
- Revenue
- AQST $58,900,000.00
- CMP $1,142,200,000.00
- Revenue This Year
- AQST $18.45
- CMP N/A
- Revenue Next Year
- AQST N/A
- CMP $7.62
- P/E Ratio
- AQST N/A
- CMP N/A
- Revenue Growth
- AQST 22.56
- CMP N/A
- 52 Week Low
- AQST $1.69
- CMP $7.51
- 52 Week High
- AQST $6.23
- CMP $27.25
- Technical
- Relative Strength Index (RSI)
- AQST 37.69
- CMP 63.43
- Support Level
- AQST $4.62
- CMP $11.41
- Resistance Level
- AQST $5.59
- CMP $12.80
- Average True Range (ATR)
- AQST 0.37
- CMP 0.93
- MACD
- AQST -0.11
- CMP -0.03
- Stochastic Oscillator
- AQST 2.54
- CMP 69.77
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Canada, the us state of Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.